Receive our newsletter – data, insights and analysis delivered to you
  1. News
January 19, 2017

M&As this week: Malin Corporation, Eli Lilly and Company

Irish life sciences company Malin Corporation has acquired 33% stake in Wren Therapeutics with the aim of developing rational therapeutic strategies.

Irish life sciences company Malin Corporation has acquired 33% stake in Wren Therapeutics with the aim of developing rational therapeutic strategies.

The target company is a UK-based biopharmaceutical organisation that is a spin out from the University of Cambridge, UK, and Lund University, Sweden.

"The acquisition terms also give Malin an option to increase its shareholding in Wren Therapeutics to 67%."

The acquisition terms also give Malin an option to increase its shareholding in Wren Therapeutics to 67%.

Eli Lilly and Company has reached an agreement to acquire a biopharmaceutical company named CoLucid Pharmaceuticals with the aim of enhancing its existing portfolio in migraine pain management and adding a potential near-term launch to its late-stage pipeline.

The acquisition is being executed through a tender offer and includes a purchase consideration of up to $960m.

Both companies involved in the acquisition are based in the US. The transaction is expected to be completed by the end of the first quarter of 2017.

Content from our partners
Why this global life sciences COO believes relocation to Charleston, SC, was key to achieving next-level success
Patient-centric pharma logistics: How CRYOPDP delivers hope worldwide
Why Asia-Pacific is the next frontier for decentralized clinical trials

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU